Healthy Subjects — Activation of A-delta-fibres and C-fibres in a First Degree Thermal Injury in Volunteers
Citation(s)
Arendt-Nielsen L, Chen AC Lasers and other thermal stimulators for activation of skin nociceptors in humans. Neurophysiol Clin. 2003 Dec;33(6):259-68. Review.
Cook AJ, Woolf CJ, Wall PD Prolonged C-fibre mediated facilitation of the flexion reflex in the rat is not due to changes in afferent terminal or motoneurone excitability. Neurosci Lett. 1986 Sep 25;70(1):91-6.
Franz M, Spohn D, Ritter A, Rolke R, Miltner WH, Weiss T Laser heat stimulation of tiny skin areas adds valuable information to quantitative sensory testing in postherpetic neuralgia. Pain. 2012 Aug;153(8):1687-94. doi: 10.1016/j.pain.2012.04.029. Epub 2012 May 31.
Johansen A, Schirmer H, Stubhaug A, Nielsen CS Persistent post-surgical pain and experimental pain sensitivity in the Tromsø study: comorbid pain matters. Pain. 2014 Feb;155(2):341-8. doi: 10.1016/j.pain.2013.10.013. Epub 2013 Oct 18.
Kehlet H, Jensen TS, Woolf CJ Persistent postsurgical pain: risk factors and prevention. Lancet. 2006 May 13;367(9522):1618-25. Review.
LaMotte RH, Lundberg LE, Torebjörk HE Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin. J Physiol. 1992 Mar;448:749-64.
Naert AL, Kehlet H, Kupers R Characterization of a novel model of tonic heat pain stimulation in healthy volunteers. Pain. 2008 Aug 15;138(1):163-71. doi: 10.1016/j.pain.2007.11.018. Epub 2008 Jan 22.
Pedersen JL, Kehlet H Hyperalgesia in a human model of acute inflammatory pain: a methodological study. Pain. 1998 Feb;74(2-3):139-51.
Pedersen JL, Kehlet H Secondary hyperalgesia to heat stimuli after burn injury in man. Pain. 1998 Jun;76(3):377-84.
Plaghki L, Mouraux A How do we selectively activate skin nociceptors with a high power infrared laser? Physiology and biophysics of laser stimulation. Neurophysiol Clin. 2003 Dec;33(6):269-77. Review.
Torebjörk HE, LaMotte RH, Robinson CJ Peripheral neural correlates of magnitude of cutaneous pain and hyperalgesia: simultaneous recordings in humans of sensory judgments of pain and evoked responses in nociceptors with C-fibers. J Neurophysiol. 1984 Feb;51(2):325-39.
Torebjörk HE, Lundberg LE, LaMotte RH Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J Physiol. 1992 Mar;448:765-80.
Werner MU, Petersen KL, Rowbotham MC, Dahl JB Healthy volunteers can be phenotyped using cutaneous sensitization pain models. PLoS One. 2013 May 9;8(5):e62733. doi: 10.1371/journal.pone.0062733. Print 2013.
Woolf CJ, Wall PD Relative effectiveness of C primary afferent fibers of different origins in evoking a prolonged facilitation of the flexor reflex in the rat. J Neurosci. 1986 May;6(5):1433-42.
Activation of A-delta-fibres and C-fibres in a First Degree Thermal Injury in Volunteers
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
